logo

Mylan N.V. (MYL)



Trade MYL now with
  Date
  Headline
2/20/2018 7:31:32 AM Mylan Receives Tentative Approval For Combination HIV Treatment DTG/FTC/TAF Under FDA's PEPFAR Program
2/1/2018 7:32:36 AM Mylan Announces U.S. Launch Of Efavirenz Tablets USP, 600 Mg, Generic Version Of Sustiva
1/29/2018 8:33:06 AM Theravance, Mylan Announce FDA Acceptance Of NDA For Revefenacin In Adults With Chronic Obstructive Pulmonary Disease
1/29/2018 6:01:06 AM Mylan, Biocon Receive Positive CHMP Opinion For Semglee, Biosimilar Insulin Glargine
1/8/2018 7:31:08 AM Mylan To Complete $1 Bln Share Repurchase Plan; Abbott Sells Remaining 20.3 Mln Shares Of Mylan
1/7/2018 9:50:22 AM New Drugs Approved In December
12/14/2017 7:35:20 AM Mylan Says PTAB Instituted IPR Proceedings On All Claims Against Two Orange Book-listed Patents
12/4/2017 7:31:45 AM Mylan And Aspen Announce Launch Of Generic Busulfex Injection
11/13/2017 9:29:40 AM Theravance And Mylan Submit NDA To FDA For Revefenacin (TD-4208) In Adults With Chronic Obstructive Pulmonary Disease
11/9/2017 7:32:04 AM Mylan Announces U.S. Launch Of Clofarabine Injection, 20 Mg/20 ML (1 Mg/mL) Single-Dose Vials